Clinical Trials Sponsored by Bionomics Limited

Total 3538 results

Direct Biologics, LLC

Not yet recruiting

Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS (EXIT-ARDS)

ARDS, Human
Direct Biologics, LLC

Not yet recruiting

ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome

Covid19 | Dyspnea | Postviral Syndrome
Aesculap Biologics, LLC

Recruiting

NOVOCART 3D Treatment Following Microfracture Failure

Articular Cartilage Defect

United States
CanSino Biologics Inc.

Active, not recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Epidemic Meningitis

China
VIVEX Biologics, Inc.

Terminated

Wound Healing Following Penile Prosthesis Implant

Erectile Dysfunction

United States
Direct Biologics, LLC

Withdrawn

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

COVID-19
Direct Biologics, LLC

Available

Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients

Solid Organ Transplant Rejection | Organ Rejection Transplants | Organ Rejection

United States
Direct Biologics, LLC

Available

Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS

Hypoxia | Covid19 | ARDS | Cytokine Storm
CanSino Biologics Inc.

Active, not recruiting

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Respiratory Tract Infections | Respiratory Tract Diseases | Pneumonia

China
CanSino Biologics Inc.

Active, not recruiting

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

COVID-19

China
CanSino Biologics Inc.

Completed

IH Convidecia as Second Booster Dose Against Breakthrough Infections

COVID-19

Malaysia
Aziyo Biologics, Inc.

Completed

CorMatrix ECM for Carotid Repair Following Endarterectomy Registry

Carotid Stenosis

United States
Aziyo Biologics, Inc.

Completed

Retrospective Experience Of CIED Implantation

Coronary Artery Disease | Heart Failure | Cardiac Disease

United States
Aziyo Biologics, Inc.

Completed

A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction (PERFORM)

Peripheral Vascular Disease
Aziyo Biologics, Inc.

Withdrawn

CIED Implantation in Low BMI Patients

Heart Diseases | Cardiac Disease
Aziyo Biologics, Inc.

Withdrawn

A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope (JUMP)

Coronary Disease
Aziyo Biologics, Inc.

Withdrawn

A Study Evaluating 3-Level OLIF Spine Fusion

Degenerative Disc Disease | Spondylolisthesis | Retrolisthesis
CanSino Biologics Inc.

Withdrawn

A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

COVID-19
Qu Biologics Inc.

Terminated

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Crohn Disease

Canada
Theriva Biologics SL

Completed

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Pancreatic Adenocarcinoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors

Spain
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors

Cancer

Italy, Netherlands
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma (NGR010)

Malignant Pleural Mesothelioma

Italy
Synthetic Biologics Inc.

Completed

A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

Healthy Volunteers With Ileostomy

Canada
Applied Biologics, LLC

Unknown

Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee (OA)

Osteoarthritis, Knee

United States
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour

Solid Tumors

Italy
Precision Biologics, Inc

Completed

QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer

Metastatic Colorectal Cancer | Metastatic Pancreatic Cancer

United States
Qu Biologics Inc.

Completed

Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease

Crohn's Disease | Inflammatory Bowel Disease

Canada
MLM Biologics Inc.,

Unknown

Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study

Skin Ulcer
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor

Solid Tumors

Italy
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Italy
Avaxia Biologics, Incorporated

Completed

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Ulcerative Colitis

United States, Hungary, Belgium, Canada
Pinnacle Biologics Inc.

Withdrawn

Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light

Esophageal Cancer | Non Small Cell Lung Cancer | High-grade Dysplasia in Barrett Esophagus
Pinnacle Biologics Inc.

Withdrawn

Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE) (Oedisse)

Barrett Esophagus
Therion Biologics Corporation

Unknown

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

Pancreatic Cancer

United States
Advanced Bionics

Completed

Non-significant Risk Study of a Cochlear Implant Headpiece

Hearing Loss | Sensorineural Hearing Loss

United States
Advanced Bionics

Completed

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders | Asymmetrical Hearing Loss | Single-Sided Deafness

United States
Burst Biologics

Unknown

Burst Biologics Spinal Fusion Registry

Degenerative Disc Disease | Spondylitis | Spinal Stenosis | Spondylolisthesis | Herniated Disk

United States
Hutchison Medipharma Limited
Nutrition Science Partners Limited

Terminated

HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis (NATRUL-4)

Ulcerative Colitis

United States
CanSino Biologics Inc.

Not yet recruiting

A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years

Meningococcal Meningitis

Indonesia
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
CanSino Biologics Inc.

Recruiting

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

Epidemic Meningitis

China
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
Forge Biologics, Inc

Recruiting

Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT (REKLAIM)

Krabbe Disease

United States
Theriva Biologics SL

Recruiting

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer (VIRAGE)

Pancreatic Adenocarcinoma | Metastatic

Spain, United States
Direct Biologics, LLC

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Acute Respiratory Distress Syndrome | ARDS

United States
TaiMed Biologics Inc.

Recruiting

TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

HIV-1-infection

United States
Direct Biologics, LLC

Recruiting

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease

Inflammatory Bowel Diseases | Crohn Disease

United States
ADMA Biologics, Inc.

Recruiting

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Primary Immune Deficiency

United States
Precision Biologics, Inc

Recruiting

Study of NEO-201 in Solid Tumors Expansion Cohorts

Cervical Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Uterine Cancer

United States
Aziyo Biologics, Inc.

Completed

A Retrospective Breast Reconstruction Study

Breast Cancer

United States

3

Subscribe